Subscribe To
Diagnos and ets to present ground-breaking research on mass screening for macular edema at arvo 2023
BROSSARD, Quebec, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) ...
February 14, 2023, 10:37 am
Cvs health cuts $10.6 billion deal to buy oak street health to expand into primary care
CVS Health Corp (NYSE:CVS) which has reportedly been in the market for a medical services acquisition since last year, agreed to snap up Oak Street He...
February 8, 2023, 11:46 am
5 peg-based value stocks to pick for your portfolio now
Here are five value stocks that passed our screening criteria - ADM, CAG, ACI, TECK and URI....
February 2, 2023, 9:02 am
Goodbody health to offer multi-cancer screening services via liquid biopsy test
Goodbody Health Ltd (AQSE:GDBY, OTCQB:GDBYF) said its network of UK clinics will start offering multi-cancer s...
January 26, 2023, 10:03 am
Better long-term buy in 2023: exact sciences or veracyte?
As cancer screenings are becoming covered more often, both companies stand to gain....
January 24, 2023, 10:23 am
5 lucrative garp stocks with discounted peg
Here are the five PEG-driven GARP stocks, CAG, TECK, SAP, DB and NRG that pass our screening criteria....
January 19, 2023, 9:02 am
First advantage announces branding of smarthub™
Focused on Improving Speed, Quality, and Cost-Effectiveness in Employment Verifications ATLANTA, Jan. 17, 2023 (GLOBE NEWSWIRE) — First Advantage Co...
January 17, 2023, 3:08 pm
Sterling check corp.: growth story with an attractive risk-reward
Sterling Check Corp. is among the largest provider of background screening and identity verification se...
January 11, 2023, 8:03 am
3 high-growth stocks with high margins to buy for big gains in the new year
Investors looking for high-growth stocks to buy in 2023 might want to change their screening criteria. ...
January 10, 2023, 5:42 am
Exact sciences raises fourth-quarter estimates above expectations
EXAS stock jumped as the provider of cancer screening and diagnostic tests raised estimates for its fou...
January 9, 2023, 12:07 pm
5 lucrative peg-driven value stocks for investors
Here are five stocks, CAG, GFI, GGB, NRG and CNM that match our screening criteria....
January 6, 2023, 9:02 am
10 top dividend aristocrat stocks to buy in 2023 - our favorite is singapore technologies engineering
"Dividend Aristocrats" is an S&P term for stocks that have raised their annual dividend every year for many years, 25 in the US or 10 internationally....
January 4, 2023, 12:00 pm
Sterling acquires socrates ltd., latin america’s largest independent background screening company
NEW YORK, Jan. 04, 2023 (GLOBE NEWSWIRE) — Sterling Check Corp. (NASDAQ: STER) (“Sterling”), a leading global provider of background ...
January 4, 2023, 12:00 pm
5 discounted peg stocks ideal for garp investors
Here are five stocks, SIG, SUZ, TME, BDORY and CNM that match our screening criteria....
December 23, 2022, 9:02 am
Fvd: equal-weight dividend etf with safety screening
FVD is a dividend ETF with a safety filter and an equal-weight methodology. It is better-balanced in sectors and holdings than the S&P 500....
December 21, 2022, 3:30 pm
Zynerba pharmaceuticals revises timeline for release of topline results from phase 3 reconnect trial of zygel in fragile x syndrome
Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) has revised its timeline for releasing topline results from its multiple-centre Phase 3 RECONNECT trial, whi...
December 21, 2022, 7:46 am
'avatar: the way of water' makes $17 million in thursday previews, driven by big 3d sales
James Cameron's "Avatar: The Way of Water" snared $17 million during early screenings on its way toward a $175 million opening weekend....
December 16, 2022, 12:24 pm
Saic wins $150m airport technology support contract from tsa
Per the latest $150 million contract from the TSA, SAIC is likely to continue performing the operational testing and evaluation of TSA airport ...
December 16, 2022, 10:32 am
Guardant health (gh) stock sinks on disappointing blood test results
Guardant Health (NASDAQ: GH ) stock dropped nearly 33% after a test of its colon-cancer screening syste...
December 16, 2022, 9:57 am
Guardant health stock plunges, exact sciences stock soars after colorectal-cancer test study results
Shares of Guardant Health Inc. tanked 40% and shares of Exact Sciences Corp. rallied more than 25% in the extended session Thursday after Guardant ann...
December 15, 2022, 5:28 pm